All Stories

  1. Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors
  2. In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes
  3. High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine
  4. Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa
  5. Chemical sensors for the early diagnosis of bacterial resistance to β-lactam antibiotics
  6. Novel Penicillin-Based Sulfone-Siderophore Conjugates for Restoring β-Lactam Antibiotic Efficacy
  7. Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins
  8. In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification
  9. Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales
  10. Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1
  11. Siderophores: Chemical tools for precise antibiotic delivery
  12. Quinate-based ligands for irreversible inactivation of the bacterial virulence factor DHQ1 enzyme—A molecular insight†
  13. Singlet oxygen and radical-mediated mechanisms in the oxidative cellular damage photosensitized by the protease inhibitor simeprevir
  14. In Silico Simulations and Functional Cell Studies Evidence Similar Potency and Distinct Binding of Pacific and Caribbean Ciguatoxins
  15. Regioselective Synthesis of 2-Aryl-5-cyano-1-(2-hydroxyaryl)-1H-imidazole-4-carboxamides Self-Assisted by a 2-Hydroxyaryl Group
  16. Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme
  17. Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections
  18. Switching from ultrafast electron transfer to proton transfer in excited drug–protein complexes upon biotransformation
  19. 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics
  20. Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.
  21. Protein Binding of Lapatinib and Its N- and O-Dealkylated Metabolites Interrogated by Fluorescence, Ultrafast Spectroscopy and Molecular Dynamics Simulations
  22. Characterization of Locally Excited and Charge‐Transfer States of the Anticancer Drug Lapatinib by Ultrafast Spectroscopy and Computational Studies
  23. Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDRPseudomonas aeruginosainfections
  24. Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection
  25. Cover Feature: Self‐Immolation of a Bacterial Dehydratase Enzyme by its Epoxide Product (Chem. Eur. J. 36/2020)
  26. Self‐Immolation of a Bacterial Dehydratase Enzyme by its Epoxide Product
  27. 6-Arylmethylidene Penicillin-Based Sulfone Inhibitors for Repurposing Antibiotic Efficiency in Priority Pathogens
  28. Investigation of metabolite-protein interactions by transient absorption spectroscopy and in silico methods
  29. β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs
  30. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone
  31. Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii
  32. Recently developed synthetic compounds with anti-infective activity
  33. Photobinding of Triflusal to Human Serum Albumin Investigated by Fluorescence, Proteomic Analysis, and Computational Studies
  34. Hydroxylammonium derivatives for selective active-site lysine modification in the anti-virulence bacterial target DHQ1 enzyme
  35. Synthesis of rigidified shikimic acid derivatives by ring-closing metathesis to imprint inhibitor efficacy against shikimate kinase enzyme
  36. Identification of a common recognition center for a photoactive non-steroidal antiinflammatory drug in serum albumins of different species
  37. The Inhibition of Lipid A Biosynthesis-The Antidote Against Superbugs?
  38. Photogeneration of Quinone Methides as Latent Electrophiles for Lysine Targeting
  39. A combined photophysical and computational study on the binding of mycophenolate mofetil and its major metabolite to transport proteins
  40. QM/MM simulations identify the determinants of catalytic activity differences between type II dehydroquinase enzymes
  41. 31.5.1.2.7 Synthesis of Phenols and Phenolates by Elimination (Update 2018)
  42. 31.5.1.1.18 Synthesis of Phenols and Phenolates by Substitution (Update 2018)
  43. 31.5.1.3.6 Synthesis of Phenols and Phenolates by Rearrangement (Update 2018)
  44. 31.5.1.4.3 Synthesis of Phenols and Phenolates with Retention of the Functional Group (Update 2018)
  45. A New Pathway for Protein Haptenation by β-Lactams
  46. Reducing the Flexibility of Type II Dehydroquinase for Inhibition: A Fragment-Based Approach and Molecular Dynamics Study
  47. Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
  48. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii
  49. Mapping a protein recognition centre with chiral photoactive ligands. An integrated approach combining photophysics, reactivity, proteomics and molecular dynamics simulation studies
  50. Frontispiece: Freezing the Dynamic Gap for Selectivity: Motion-Based Design of Inhibitors of the Shikimate Kinase Enzyme
  51. Freezing the Dynamic Gap for Selectivity: Motion-Based Design of Inhibitors of the Shikimate Kinase Enzyme
  52. Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme
  53. LN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48
  54. ChemInform Abstract: Designing Irreversible Inhibitors - Worth the Effort?
  55. Study of the Phosphoryl-Transfer Mechanism of Shikimate Kinase by NMR Spectroscopy
  56. Degradation of the active species in the catalytic system Pd(OAc)2/NEt3
  57. Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies
  58. Designing Irreversible Inhibitors-Worth the Effort?
  59. Specific chemical modification of bacterial type I dehydroquinase – opportunities for drug discovery
  60. Hydrolysis of imidazolidine ligands mediated by CuII: Mononuclear, tetranuclear and 1D CuII-amine complexes
  61. Chemical Modification of a Dehydratase Enzyme Involved in Bacterial Virulence by an Ammonium Derivative: Evidence of its Active Site Covalent Adduct
  62. Using Surface Enhanced Raman Scattering to Analyze the Interactions of Protein Receptors with Bacterial Quorum Sensing Modulators
  63. Irreversible covalent modification of type I dehydroquinase with a stable Schiff base
  64. Bridging the Dimensions: How 2D Structure-activity Relationships and 3D Structural Binding Affinity help to Guide Medicinal Chemistry
  65. Total Hydrolysis of a New Imidazolidine Induced by ZnII
  66. Insights into substrate binding and catalysis in bacterial type I dehydroquinase
  67. Exploring the Water-Binding Pocket of the Type II Dehydroquinase Enzyme in the Structure-Based Design of Inhibitors
  68. Mechanistic insight into the reaction catalysed by bacterial type II dehydroquinases
  69. Dual role of 2-tosylaminomethylaniline as a ligand and a nucleophile in the copper-mediated oxidation of methanol
  70. Irreversible covalent modification of type I dehydroquinase: Structure-based design and simulation studies
  71. Predicting ligand binding affinity: A comparative study on the use of docking vs. Bayesian categorization and random forest recursive partitioning
  72. A convenient Pd-mediated oxidation of 4-methylbenzyl alcohol
  73. Computational studies on the palladium-mediated oxidation of methanol to formaldehyde
  74. Copper-mediated aerobic synthesis of 3-tosyl-1,2,3,4-tetrahydroquinazoline from 2 tosylaminomethylaniline and methanol
  75. Mechanistic insights into a Zn-assisted ring-chain tautomerism process involving a 1,2,3,4-tetrahydroquinazoline and a Schiff base
  76. Mycobacterium tuberculosis Shikimate Kinase Inhibitors: Design and Simulation Studies of the Catalytic Turnover
  77. Comparative Binding Energy (COMBINE) Analysis for Understanding the Binding Determinants of Type II Dehydroquinase Inhibitors
  78. Serendipitous formation of 3-tosyl-1,2,3,4-tetrahydroquinazoline
  79. Design and investigation of multivalent ligands for the detection and treatment of diseases
  80. Structure of Helicobacter pylori Type II Dehydroquinase inhibited by (2S)-2-(4-methoxy)benzyl-3-dehydroquinic acid
  81. Structure of Helicobacter pylori Type II Dehydroquinase inhibited by (2S)-2-Perfluorobenzyl-3-dehydroquinic acid
  82. Mechanistic Basis of the Inhibition of Type II Dehydroquinase by (2S)- and (2R)-2-Benzyl-3-dehydroquinic Acids
  83. ChemInform Abstract: Six-Membered Heterocycles: Pyridines
  84. Metal-Assisted Ring-Closing/Opening Process of a Chiral Tetrahydroquinazoline
  85. Structural variety of zinc and copper complexes based on a 2,3-disubstituted 1,2,3,4-tetrahydroquinazoline ligand
  86. Synthesis of 3-alkyl enol mimics inhibitors of type II dehydroquinase: factors influencing their inhibition potency
  87. Benzenediazonium-2-carboxylate
  88. A Prodrug Approach for Improving Antituberculosis Activity of Potent Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors
  89. Six-Membered Heterocycles: Pyridines
  90. C. González-Bello
  91. Tetrahydrobenzothiophene Derivatives: Conformationally Restricted Inhibitors of Type II Dehydroquinase
  92. Understanding the Key Factors that Control the Inhibition of Type II Dehydroquinase by (2R)‐2‐Benzyl‐3‐dehydroquinic Acids
  93. ChemInform Abstract: Synthesis of 4-Deoxyquinic, 4-Deoxyshikimic and 4-Deoxy-3-dehydroshikimic Acid.
  94. Functional desymmetrization of 1,3-dioximes for the obtention of 1,2,3-hetero trisubstituted carbocycles
  95. Chiral Aziridination of Olefins Using a Chiral Sulfinamide as the Nitrogen Source
  96. Synthesis and Biological Evaluation of New Nanomolar Competitive Inhibitors of Helicobacter pylori Type II Dehydroquinase. Structural Details of the Role of the Aromatic Moieties with Essential Residues
  97. 2-Substituted-3-Dehydroquinic Acids as Potent Competitive Inhibitors of Type II Dehydroquinase
  98. A selective resin for trans-diequatorial-1,2-diols
  99. ChemInform Abstract: The Conformational Rigidity of Butane-1,2-diacetals as a Powerful Synthetic Tool
  100. Stereoselective Synthesis of Novel Cyclic γ-Amino Acids and Triazole Derivatives
  101. Competitive Inhibitors of Helicobacter pylori Type II Dehydroquinase: Synthesis, Biological Evaluation, and NMR Studies
  102. Editorial [ The Medicinal Chemistry of Anti-Infectious Agents Guest Editor: Concepcion Gonzalez-Bello ]
  103. The conformational rigidity of butane-1,2-diacetals as a powerful synthetic tool
  104. Progress in Type II Dehydroquinase Inhibitors: From Concept to Practice
  105. Nanomolar Competitive Inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor Type II Dehydroquinase
  106. Cover Picture: Nanomolar Competitive Inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor Type II Dehydroquinase (ChemMedChem 2/2007)
  107. Nanomolar Inhibition of Type II Dehydroquinase Based on the Enolate Reaction Mechanism
  108. Progress in type II dehydroquinase inhibitors: From concept to practice
  109. Determination of the Bound Conformation of a Competitive Nanomolar Inhibitor of Mycobacterium tuberculosis Type II Dehydroquinase by NMR Spectroscopy
  110. Synthesis of Spiro Carba-Sugars by Ring-Closing Metathesis
  111. Structure-Based Design, Synthesis, and Biological Evaluation of Inhibitors of Mycobacterium tuberculosis Type II Dehydroquinase
  112. Rational design of new bifunctional inhibitors of type II dehydroquinase
  113. Synthesis of Amino Carba Sugars and Conformationally Restricted Polyhydroxyγ-Amino Acids from (−)-Quinic Acid
  114. Parallel Solid-Phase Synthesis and Evaluation of Inhibitors of Streptomyces coelicolor Type II Dehydroquinase
  115. Synthesis of Polyhydroxycyclohexanes and Relatives from (−)-Quinic Acid
  116. Mild, Aprotic Synthesis of 1,2‐Diacetals.
  117. Design, synthesis and evaluation of bifunctional inhibitors of type II dehydroquinase
  118. Mild, aprotic synthesis of 1,2-diacetals
  119. ChemInform Abstract: Synthesis of Carba‐Sugars from (‐)‐Quinic Acid.
  120. Synthesis of carba-sugars from (−)-quinic acid
  121. Benzenediazonium-2-carboxylate
  122. Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase
  123. Mechanistic studies on type I and type II dehydroquinase with (6 R )- and (6 S )-6-fluoro-3-dehydroquinic acids
  124. Synthesis of phenanthridones, quinolinequinones and 7-azasteroids
  125. Synthesis of 4-deoxyquinic, 4-deoxyshikimic and 4-deoxy-3-dehydroshikimic acids
  126. Synthesis of 2-Bromo- and 2-Fluoro-3-dehydroshikimic Acids and 2-Bromo- and 2-Fluoroshikimic Acids Using Synthetic and Enzymatic Approaches
  127. Synthesis of (2R)-2-bromodehydroquinic acid and (2R)-2-fluorodehydroquinic acid
  128. Synthesis of tetrahydroquinolines, hexahydrobenzoindolizines and an aryl phosphonate linker for the generation of catalytic antibodies
  129. Evidence from kinetic isotope studies for an enolate intermediate in the mechanism of type II dehydroquinases
  130. A new intramolecular aryne cycloaddition approach to lycorines
  131. Synthesis of lycorines by intramolecular aryne cycloadditions
  132. Total Synthesis of (-)-Neplanocin A from L-Ribulose
  133. New Methods for Synthesis of Amaryllidaceae Alkaloids